Baxter's HemAssist could lift stock to new highs
Malcolm Berko analyzes Baxter International a $6.5 billion health care firm with four divisions renal intravenous cardiovascular biotech and a promising HemAssist blood substitute in European Phase III trials and potential U.S. approval within a year. If HemAssist reaches projections Baxter could see $100 a share in three to five years.
MENTIONED IN THIS ARTICLE
Baxter International
Baxter
Europe
United States
Wall Street
Biotech
Baxter Biotech
HemAssist
France
Germany
Italy
U.S
Survey finds vacation planning eclipses fund research
A nationwide 750-person survey commissioned by Montgomery Asset Management shows people spend about 28 days planning vacations but only nine days choosing funds. It reveals mixed views on Hong Kong exposure, Dow shifts, and fund buying behavior, with extensive demographic details and fee structures for advisory services.
MENTIONED IN THIS ARTICLE
Tahiti
Montgomery Asset Management
Intersearch Corp
Hong Kong
China
Toie
Banking checks and overdraft rules debated
A reader questions Planey Bank policy on posting deposits versus checks and faces overdraft fees. An expert notes banks decide posting order, suggests overdraft protection, and advises thorough record keeping and shopping for service terms. Contact details for the Consumer Credit Counseling Service of Central New York are provided.
MENTIONED IN THIS ARTICLE
Sharon Patchett
Consumer Credit Counseling Service
Central New York
Salina St
Syracuse
N.Y
Know your rights on unordered merchandise rights column
Readers learn how to handle unordered gifts and free samples, including keeping shipments as free gifts, sending a written notice to prevent further bills, or returning items at seller expense. Advice covers contacting the seller, documenting orders, and seeking help from postal inspectors or the BBB in Central New York.
MENTIONED IN THIS ARTICLE
U.S
Jeanne Casinella
Better Business Bureau
Central New York
Better Business
Winners See Only Good Times Ahead in Mutual Funds
Top fund managers say a strong economy could push the Dow to 10,000 by 1999. William Miller of Legg Mason Value fund led long term growth with 52 percent return. Chris Davis of Selected American Shares gained 45 percent. Several managers expect higher inflation and rates are unlikely soon. The Fed is not expected to raise rates soon, and tech growth remains a driver.
MENTIONED IN THIS ARTICLE
Meyers Benet
Lipper Mutual
Fusmas
Ford Tronz
Dreman Value Management
Red Bank
N.J
Kemper
Dreman
Kemper-Dreman High Return Equity
Zurich Kemper Investments
Chicago
Dreman Value Advisors
Zurich Kemper Value Advisors
Thomas Sassi
Kemper- Dreman
Jonathan Kay
Christian Bertelsen
Phoenix Duff & Phelps
Kemper-Dreman
Bertelsen
Tom Forester
Steven Stokes
New York
Boston
Dow
William Miller
Legg Mason Value
Miller
U.S
Chris Davis
Fed
David Alger
Alger Capital Appreciation
Also Mentioned on This Page
Malcolm Berko
Copley News Service
The
Herald-Journal
Berko
Syracuse Herald- Journal
P.O. Box
Boca Raton
Fla
Space Mountain
Disneyland
Blue Chip
OTC
Iwaluuliv
Lipper Mutual Funds
Lipper International
FE U.S. Savings , Bonds
SIM
Upper Mutual
Pirates of the
Montgomery
Fidelity
Idelity Investments
Zurich
David N. Dreman
Fis
Leeann Ha Dehn Kewk Ad
Yguare
Steven T. Goldberg
Kiplinger's Magazine
Thomases
James Oelschlager
White Oak Growth Fund
This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!